IP Library Patent Application 13471364
Patent Application Utility Small
App. No. 13/471,364 · Confirmation No. 4051

ORAL FORMULATIONS OF DIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS TO TREAT ELEVATED BLOOD PRESSURE AND DIABETIC NEPHROPATHY

Abandoned -- Incomplete Application (Pre-examination)
⬇ PDF
Code Description Pages PDF
2013-02-11 ABN Abandonment 2 View
2012-12-31 NT.INC.REPLY Notice of Incomplete Reply 2 View
2012-12-31 WFEE Fee Worksheet (SB06) 1 View
2012-12-19 PEFR Applicant Response to Pre-Exam Formalities Notice 1 View
2012-12-19 WFEE Fee Worksheet (SB06) 2 View
2012-12-19 N417 Electronic Filing System Acknowledgment Receipt 2 View
2012-12-19 XT/ Extension of Time 1 View
2012-06-18 WFEE Fee Worksheet (SB06) 1 View
2012-06-18 NT.INC.REPLY Notice of Incomplete Reply 2 View
2012-06-12 LET. Miscellaneous Incoming Letter 1 View
2012-06-12 N417 Electronic Filing System Acknowledgment Receipt 2 View
2012-05-30 NTC.MISS.PRT Notice to File Missing Parts 2 View
2012-05-30 APP.FILE.REC Filing Receipt 3 View
2012-05-30 WFEE Fee Worksheet (SB06) 1 View
2012-05-14 A.PE Preliminary Amendment 1 View
2012-05-14 SPEC Specification 1 View
2012-05-14 ABST Abstract 1 View
2012-05-14 CLM Claims 4 View
2012-05-14 REM Applicant Arguments/Remarks Made in an Amendment 1 View
2012-05-14 N417 Electronic Filing System Acknowledgment Receipt 3 View
2012-05-14 ADS Application Data Sheet 6 View
2012-05-14 SPEC Specification 85 View
2012-05-14 CLM Claims 6 View
2012-05-14 ABST Abstract 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
13/471,364
Filed
2012-05-14
Art Unit
1629